Cullinan Therapeutics, Inc.
CGEM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51 | -$70 | -$49 | -$48 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $10 | $9 | $10 |
| Change in WC | $6 | $4 | -$2 | $5 |
| Other Non-Cash | $8 | -$2 | -$2 | -$4 |
| Operating Cash Flow | -$37 | -$58 | -$43 | -$37 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$13 | -$79 | -$126 | -$168 |
| Inv. Sales/Matur. | $80 | $132 | $163 | $184 |
| Other Inv. Act. | -$0 | $0 | $0 | $0 |
| Investing Cash Flow | $67 | $53 | $37 | $16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $2 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $31 | -$4 | -$6 | -$19 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $73 | $77 | $83 | $102 |
| End Cash | $103 | $73 | $77 | $83 |
| Free Cash Flow | $0 | -$58 | -$43 | -$37 |